Apellis says EU regulator panel may not back its eye disease drug

Apellis Pharmaceuticals

14/12/2023 12:12

Dec 14 (Reuters) - Apellis Pharmaceuticals  APLS.O  said
on Thursday the European drug regulator's advisory panel may
decline to back an authorization for the company's drug for a
chronic eye disease.

 (Reporting by Leroy Leo in Bengaluru; Editing by Mrigank
Dhaniwala)
 ((Leroy.Dsouza@thomsonreuters.com ; https://twitter.com/LeroyLeo7;))